Measuring the tyrosine kinase activity: A review of biochemical and cellular assay technologies

Expert Opinion on Drug Discovery

Volumn 3, Issue 8, 2008, Pages 959-978

  Jia, Yong ^a   Gu, Xiang Ju ^a   Brinker, Achim ^a   Warmuth, Markus ^a  

^a GENOMICS INSTITUTE OF THE NOVARTIS RESEARCH FOUNDATION   (United States)

Author keywords

Assay; Biochemical; Cellular; Phospho specific antibodies; Radiometric; Tyrosine kinase

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; PROTEIN TYROSINE KINASE;

BIOTECHNOLOGY; ELECTROCHEMICAL ANALYSIS; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; FLUORESCENCE POLARIZATION IMMUNOASSAY; FLUORESCENCE RESONANCE ENERGY TRANSFER; FLUOROIMMUNOASSAY; IMMUNORADIOMETRIC ASSAY; MICROFLUIDIC ANALYSIS; PHOTOCHEMICAL QUENCHING; PRIORITY JOURNAL; REVIEW; SCINTILLATION PLATE ASSAY; WESTERN BLOTTING;

EID: 48749115051     PISSN: 17460441     EISSN: None     Source Type: Journal    
DOI: 10.1517/17460441.3.8.959     Document Type: Review

References (85)

1. Manning G, Whyte DB, Martinez R, et al. The protein kinase complement of the human genome. Science 2002;298:1912-34
2. Hunter T. Signaling - 2000 and beyond. Cell 2000;100:113-27
3. Mazitschek R, Giannis A. Inhibitors of angiogenesis and cancer related receptor tyrosine kinases. Curr Opin Chem Biol 2004;8:432-41
4. Myers MR, He W, Hulme C. Inhibitors of tyrosine kinases involved in inflammation and autoimmune disease. Curr Pharm Des 1997;3:473-502
5. Vlahos CJ, McDowell SA, Clerk A. Kinases as therapeutic targets for heart failure. Nat Rev Drug Discov 2003;2:99-113
6. Resnick L, Fennell M. Targeting JNK3 for the treatment of neurodegenerative disorders. Drug Discov Today 2004;9:932-39
7. Cohen P. The development and therapeutic potential of protein kinase inhibitors. Curr Opin Chem Biol 1999;3:459-65
8. Cohen P. Protein kinases - the major drug targets of the twenty-first century? Nat Rev Drug Discov 2002;1:309-15
9. Levitzki A. Protein kinase inhibitors as a therapeutic modality. Acc Chem Res 2003;36:462-9
10. Blume-Jensen P, Hunter, T. Oncogenic kinase signaling. Nature 2001;411:355-65
11. Schlessinger J. Cell signaling by receptor tyrosine kinases. Cell 2000;103:211-25
12. Medinger M, Drevs J. Receptor tyrosine kinases and anticancer therapy. Curr Pharm Des 2005;11:1139-49
13. Traxler P. Tyrosine kinases as targets in cancer therapy - successes and failures. Expert Opin Ther Targets 2003;7:215-34
14. Drevs J, Medinger M, Schmidt-Gersbach C, et al. Receptor tyrosine kinases: the main targets for new cancer therapy. Curr Drug Targets 2003;4:113-21
15. Morin MJ. From oncogene to drug: development of small molecule tyrosine kinase inhibitors as anti-tumor and anti-angiogenic agents. Oncogene 2000;19:6574-83
16. Busse D, Yakes FM, Lenferink AE, Arteaga CL. Tyrosine kinase inhibitors: rationale, mechanisms of action, and implications for drug resistance. Semin Oncol 2001;28:47-55
17. Yano S, Yamaguchi M, Dong RP. EGFR tyrosine kinase inhibitor "gefitinib (Iressa)" for caner therapy. Nippon Yakurigaku Zasshi 2003;122:491-7
18. Minor L. Assays for membrance tyrosine kinase receptors: methods for high-throughput screening and utility for diagonistics. Expert Rev Mol Daign 2005;5:561-71
19. Sittampalam GS, Kahl SD, Janzen WP. High-throughput screening: advances in assay technologies. Curr Opin Chem Biol 1997;1:384-91
20. Zaman GJR, Garritsen A, de Boer TH, van Boeckel CAA. Fluorescence assays for high-throughput screening of protein kinases. Comb Chem High Throughput Screen 2003;6:313-20
21. von Ahsen O, Bömer U. High-throughput screening for kinase inhibitors. ChemBioChem 2005;6:481-90
22. Nikiforov TT, Simeonov AM. Application of fluorescence polarization to enzyme assays and single nucleotide polymorphism genotyping: some recent development. Comb Chem High Throughput Screen 2003;6:201-12
23. Boutin JA. Tyrosine protein kinase assays. J Chromotography B 1996;684:179-99
24. Schaefer EM, Guimond S. Detection of protein kinase activity using a high-capacity streptavidin-coated membrane and optimized biotinylated peptide substrate. Anal Biochem 1998;261:100-12
25. Park Y-W, Cummings RT, Wu L, et al. Homogeneous proximity tyrosine kinase assays: scintillation proximity assay versus homogeneous time-resolved fluorescence. Anal Biochem 1999;269:94-104
26. Ohml N, Wingfield JM, Yazawa H, Inagaki O. Development of a homogeneous time-resolved fluorescence assay for high-throughput screening to identify Lck inhibitors: comparison with scintillation proximity assay and streptavidin-coated plate assay. J Biomol Screen 2000;5:463-70
27. Sun C, Newbatt Y, Douglas L, et al. High-throughput screening assay for identification of small molecule inhibitors of Aurora2/STK15 kinase. J Biomol Screen 2004;9:391-6
28. McDonald OB, Chen WJ, Ellis B, et al. A scintillation proximity assay for the Raf/MEK/ERK kinase cascade: high-throughput screening and identification of selective enzyme inhibitors. Anal Biochem 1999;268:318-29
29. Angeles TS, Steffler C, Bartlett BA, et al. Enzyme-linked immunosorbent assay for trkA tyrosine kinase activity. Anal Biochem 1996;236:49-55
30. Newbatt Y, Burns S, Hayward R, et al. Identification of inhibitors of the kinase activity of oncogenic V600EBRAF in an enzyme cascade high-throughput screen. J Biomol Screen 2006;11:145-54
31. Mathis G. HTRF technology. J Biomol Screen 1999;4:309-13
32. Mathis G. Probing molecular interactions with homogeneous techniques based on rare earth cryptates and fluorescence energy transfer. Clin Chem 1995;41:1391-7
33. Mathis G. Rare earth cryptate and homogeneous fluoroimmunoassays with human sera. Clin Chem 1993;39:1953-9
34. Hemmilä I. LANCE: homogeneous assay platform for HTS. J Biomol Screen 1999;4:303-7
35. Moshinsky DJ, Ruslim L, Blake RA, Tang F. A widely applicable, high-throughput TR-FRET assay for the measurement of kinase autophosphorylation: VEGFR-2 as a prototype. J Biomol Screen 2003;8:447-52
36. von Ahsen O, Schmidt A, Klotz M, Parczyk K. Assay concordance between SPA and TR-FRET in high-throughput screening. J Biomol Screen 2006;11:606-16
37. Jia Y, Quinn CM, Gagnon AI, Talanian R. Homogeneous time-resolved fluorescence and its applications for kinase assays in drug discovery. Anal Biochem 2006;356:273-81
38. Seethala R, Menzel R. A homogeneous, fluorescence polarization assay for Src-family tyrosine kinases. Anal Biochem 1997;253:210-8
39. Seethala R, Menzel R. A fluorescence polarization competition immunoassay for tyrosine kinases. Anal Biochem 1998;255:257-62
40. Seethala R. Fluorescence polarization competition immunoassay for tyrosine kinases. Methods 2000;22:61-70
41. Klumpp M, Boettcher A, Becker D, et al. Readout technologies for highly miniaturized kinase assays applicable to high-throughput screening in a 1536-well format. J Biomol Screen 2006;11:617-33
42. Hubert CL, Sherling SE, Johnston PA, Stancato LF. Data concordance from a comparison between filter binding and fluorescence polarization assay formats for identification of ROCK-II inhibitors. J Biomol Screen 2003;8:399-409
43. Parker GJ, Law TL, Lenoch FL, Bolger RE. Development of high throughput screening assays using fluorescence polarization: nuclear receptor-ligand-binding and kinase/phosphatase assays. J Biomol Screen 2000;5:77-88
44. Fowler A, Swift D, Longman E, et al. An evaluation of fluorescence polarization and lifetime discriminated polarization for high throughput screening of serine/threonine kinases. Anal Biochem 2002;308:223-31
45. Coffin J, Latev M, Bi X, Nikiforov TT. Detection of phosphopeptides by fluorescence polarization in the presence of cationic polyamino acids: application to kinase assays. Anal Biochem 2000;278:206-12
46. Burke TJ, Loniello KR, Beebe JA, Ervin KM. Development and application of fluorescence polarization assays in drug discovery. Comb Chem High Throughput Screen 2003;6:183-94
47. Owicki JC. Fluorescence polarization and anisotropy in high throughput screening: perspectives and primer. J Biomol Screen 2000;5:297-306
48. Warner G, Illy C, Pedro L, et al. AlphaScreen kinase HTS platforms. Curr Med Chem 2004;11:721-30
49. Leoprechting SV, Kumpf R, Menzel S, et al. Miniaturization and validation of a high-throughput serine kinase assay using the Alpha Screen plateform. J Biomol Screen 2004;9:719-25
50. Wu X, Sills MA, Zhang JH. Further comparison of primary hit identification by different assay technologies and effects of assay measurement variability. J Biomol Screen 2005;10:581-9
51. Burns S, Travers J, Collins I, et al. Identification of small-molecule inhibitors of protein kinase B (PKB/AKT) in an AlphaScreen™ high-throughput Screen. J Biomol Screen 2006;11:822-7
52. Turek-Etienne TC, Kober TP, Stafford JM, Bryant RW. Development of a fluorescence polarization AKT serine/threonine kinase assay using an immobilized metal ion affinity-based technology. Assay Drug Dev Technol 2003;1:545-53
53. Loomans EEMG, van Doornmalen AM, Wat JWY, Zaman GJR. High-throughput screening with immobilized metal ion affinity-based fluorescence polarization detection, a homogeneous assay for protein kinases. Assay Drug Dev Technol 2003;1:445-53
54. Gaudet EA, Huang K-S, Zhang Y, et al. A homogeneous fluorescence polarization assay adaptable for a range of protein serine/threonine and tyrosine kinases. J Biomol Screen 2003;8:164-75
55. Perrin D, Marin T, Cambet Y, et al. Overcoming the hurdle of fluorescence compounds in kinase screening: a case study. Assay Drug Dev Technol 2006;4:185-96
56. Singh P, Lillywhite B, Bannaghan C, Broad P. Using IMAP technology to identify kinase inhibitors: comparison with a substrate depletion approach and analysis of the nature of false positives. Comb Chem High Throughput Screen 2005;8:319-25
57. Wu G, Yuan Y, Hodge CN. Determining appropriate substrate conversion for enzymatic assays in high-throughput screening. J Biomol Screen 2003;8:694-700
58. Cohen CB, Chin-Dixon E, Jeong S, Nikiforov TT. A microchip-based enzyme assay for protein kinase A. Anal Biochem 1999;273:89-97
59. Perrin D, Fremaux C, Scheer A. Assay development and screening of a serine/threonine kinase in a on-chip mode using Caliper nanofluidics technology. J Biomol Screen 2006;11:359-68
60. Morgan AG, McCauley TJ, Stanaitis ML, et al. Development and validation of a fluorescence technology for both primary and secondary screening of kinases that facilitates compound selectivity and site-specific inhibitor determination. Assay Drug Dev Technol 2004;2:171-81
61. Xia W, Rininsland F, Wittenburg SK, et al. Applications of fluorescent polymer superquenching to high throughput screening assay for protein kinases. Assay Drug Dev Technol 2004;2:183-92
62. Wittenburg S, Stankewicz C, Rininsland F. Biotinylated peptides for rapid identification of substrates and inhibitors of kinases and phosphatases with fluorescence superquenching. Assay Drug Dev Technol 2006;4:535-43
63. Rininisland F, Xia W, Wittenburg S, et al. Metal ion-mediated polymer superquenching for highly sensitive detection of kinase and phosphatase activities. Proc Natl Acad Sci USA 2004;101:15295-300
64. Rodems SM, Hamman BD, Lin C, et al. A FRET-based assay platform for ultra-high density drug screening of protein kinases and phosphates. Assay Drug Dev Technol 2002;1:9-19
65. Johnson SR, Padmanabha R, Vaccaro W, et al. A simple strategy for mitigating the effect of data variability on the identification of active chemotypes from high-throughput screening data. J Biomol Screen 2007;12:276-84
66. Kupcho K, Somberg R, Bulleit B, Goueli SA. A homogeneous, nonradioactive high-throughput fluorogenic protein kinase assay. Anal Biochem 2003;317:210-7
67. Singh P, Harden BJ, Lillywhite BJ, Broad PM. Identification of kinase inhibitors by an ATP depletion method. Assay Drug Dev Technol 2004;2:161-9
68. Ishida A, Yoshikawa T, Kamidate T. Firefly bioluminescence assay of ATP using diethylaminoethyl-dextran as an enhancer in the presence of sodium chloride and ATP extractant. Anal Biochem 2003;316:127-30
69. Koresawa M, Okabe T. High-throughput screening with quantitation of ATP consumption: a universal non-radioisotope homogenous assay for protein kinase. Assay Drug Dev Technol 2004;2:153-60
70. Charter NW, Kauffman L, Singh R, Eglen RM. A generic homogenous method for measuring kinase and inhibitor activity via adenosine 5′-diphosphate accumulation. J Biomol Screen 2006;11:390-9
71. Gowan SM, Hardcastle A, Hallsworth AE, et al. Application of meso scale technology for the measurement of phosphoproteins in human tumor xenografts. Assay Drug Dev Technol 2007;5:391-401
72. Mellentin-Michelotti J, Evangelista LT, Swartzman EE, et al. Determination of ligand binding affinities for endogenous seven-transmembrane receptors using fluorometric microvolume assay technology. Anal Biochem 1999;272:182-90
73. Robers MB, Horton RA, Bercher MR, et al. High-throughput cellular assays for regulated posttranslational modifications. Anal Biochem 2008;372:189-97
74. Adams DG, Wang Y, Mak PA, et al. Cellular Ser/Thr kinase assays using generic peptide substrates. Curr Chem Genomics 2008;1:54-64
75. Melnick JS, Janes J, Kim S, et al. An efficient rapid system for profiling the cellular activities of molecular libraries. Proc Natl Acad Sci USA 2006;103:3153-8
76. Korn K, Krausz E. Cell-based high-content screening of small-molecule libraries. Curr Opin Chem Biol 2007;11:503-10
77. Carpenter AE. Image-based chemical screening. Nat Chem Biol 2007;3(8):461-5
78. Marine S, Zamiara E, Smith ST, et al. A miniaturized cell-based fluorescence resonance energy transfer assay for insulin-receptor activation. Anal Biochem 2006;355:267-77
79. Zhang J, Ma Y, Taylor SS, Tsien RY. Genetically encoded reporters of protein kinase A activity reveal impact of substrate tethering. Proc Natl Acad Sci USA 2001;98:14997-5002
80. Ting AY, Kain KH, Klemke RL, Tsien RY. Genetically encoded fluorescent reporters of protein tyrosine kinase activities in living cells. Proc Natl Acad Sci USA 2001;98:15003-8
81. Violin JD, Zhang J, Tsien RY, Newton AC. A genetically encoded fluorescent reporter reveals oscillatory phosphorylation by protein kinase C. J Cell Biol 2003;161:899-909
82. Zhang L, Lee KC, Bhojani MS, et al. Molecular imaging of Akt kinase activity. Nat Med 2007;13:1114-9
83. Daley GQ, Baltimore D. Transformation of an interleukin 3-dependent hematopoietic cell line by the chronic myelogenous leukemia-specific P210bcr/abl protein. Proc Natl Acad Sci USA 1988;85:9312-6
84. Beasley JR, McCoy PM, Walker TL, Dunn DA. Miniaturized, ultra-high throughput screening of tyrosine kinases using homogeneous, competitive fluorescence immunnoassays. Assay Drug Dev Technol 2004;2:141-51
85. Pommereau A, Pap E, Kannt A. Two simple and generic antibody-independent kinase assays: comparison of a bioluminescent and a microfluidic assay format. J Biomol Screen 2004;9:409-16